首页> 外文期刊>International Orthopaedics >c-Jun N-terminal kinase and nuclear factor κB mediate nitric oxide-induced expression of matrix metalloproteinase-13
【24h】

c-Jun N-terminal kinase and nuclear factor κB mediate nitric oxide-induced expression of matrix metalloproteinase-13

机译:c-Jun N末端激酶和核因子κB介导一氧化氮诱导的基质金属蛋白酶-13表达

获取原文
获取原文并翻译 | 示例
       

摘要

The purpose of this study was to investigate the mechanism of expression of matrix metalloproteinase-13 (MMP-13) induced by nitric oxide (NO). Human chondrocytes (HCs) were stimulated with a NO donor (MAHMA-NONOate), then mitogen-activated protein kinases’ (MAPKs) and nuclear factor κB’ (NF-κB) activations and MMP-13′ expression were assayed by Western blot analysis. Additionally, the intracellular signalling of NO was investigated using the inhibitors of MAPKs and NF-κB. NO-induced MMP-13 expression was not suppressed by extracellular signal-regulated kinase (ERK) inhibitor (PD98059) or inhibitors of p38 kinase (SB203580), but was inhibited by a c-jun terminal kinase (JNK) inhibitor (SP600125) and inhibitors of NF-κB (SN-50). Additionally, SP600125 treatment reduced NF-κB activation, but SN-50 treatment did not significantly affect JNK activation. These results suggest that NO induces MMP-13 expression by JNK and NF-κB activation in HCs.
机译:这项研究的目的是研究一氧化氮(NO)诱导的基质金属蛋白酶-13(MMP-13)的表达机制。用NO供体(MAHMA-NONOate)刺激人软骨细胞(HCs),然后通过蛋白质印迹分析测定促分裂原活化蛋白激酶(MAPK)和核因子κB'(NF-κB)的活化以及MMP-13'的表达。另外,使用MAPK和NF-κB的抑制剂研究了NO的细胞内信号传导。 NO诱导的MMP-13表达不受细胞外信号调节激酶(ERK)抑制剂(PD98059)或p38激酶抑制剂(SB203580)的抑制,但被c-jun末端激酶(JNK)抑制剂(SP600125)抑制和NF-κB(SN-50)抑制剂。此外,SP600125处理降低了NF-κB的活化,但是SN-50处理并未显着影响JNK的活化。这些结果表明,NO通过HCs中的JNK和NF-κB激活诱导MMP-13表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号